Compounds > tranylcypromine
Page last updated: 2024-08-22

tranylcypromine and vorinostat

tranylcypromine has been researched along with vorinostat in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyata, N; Suzuki, T1
Catanzaro, E; Fimognari, C; Marchetti, C; Mazzone, R; Milelli, A; Minarini, A; Tomaselli, D; Tumiatti, V; Turrini, E1
Aldape, K; Barton, MC; Bhat, KP; Chandra, J; Manton, CA; Singh, MM; Tsai, WW1
Barton, M; Chandra, J; Flores, ER; Johnson, B; Lang, F; Singh, MM; Su, X; Venkatarayan, A; Zhang, J1
Fisher, CA; Gibbons, RJ; Higgs, DR; Mettananda, S; Oppermann, U; Sloane-Stanley, JA; Taylor, S1

Reviews

1 review(s) available for tranylcypromine and vorinostat

ArticleYear
Lysine demethylases inhibitors.
    Journal of medicinal chemistry, 2011, Dec-22, Volume: 54, Issue:24

    Topics: Animals; Flavins; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Models, Molecular; Protein Conformation

2011

Other Studies

4 other study(ies) available for tranylcypromine and vorinostat

ArticleYear
Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors.
    Bioorganic & medicinal chemistry letters, 2018, 04-01, Volume: 28, Issue:6

    Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Histone Deacetylase 1; Histone Deacetylase Inhibitors; Humans; MCF-7 Cells; Molecular Structure; Polyamines; Structure-Activity Relationship

2018
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.
    Neuro-oncology, 2011, Volume: 13, Issue:8

    Topics: Acetylation; Astrocytes; Blotting, Western; Brain Neoplasms; Caspases; Cells, Cultured; DNA Methylation; Drug Synergism; Glioblastoma; Histone Deacetylase Inhibitors; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Monoamine Oxidase Inhibitors; Neoplastic Stem Cells; Neural Stem Cells; RNA, Small Interfering; Tranylcypromine; Vorinostat

2011
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma.
    Neuro-oncology, 2015, Volume: 17, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Female; Glioblastoma; High-Throughput Nucleotide Sequencing; Histone Deacetylase Inhibitors; Histone Demethylases; Humans; Hydroxamic Acids; Immunoblotting; Mice; Mice, Nude; Neoplastic Stem Cells; Polymerase Chain Reaction; Transcriptome; Tranylcypromine; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays

2015
Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia.
    Haematologica, 2017, Volume: 102, Issue:3

    Topics: alpha-Globins; Antigens, CD34; beta-Thalassemia; Butyric Acid; Cell Culture Techniques; Enzyme Inhibitors; Erythroid Cells; Gene Expression Profiling; Gene Expression Regulation; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Hydroxyquinolines; Hydroxyurea; Molecular Sequence Annotation; Piperazines; RNA, Small Interfering; Small Molecule Libraries; Tranylcypromine; Vorinostat

2017